- Open Access
Influence of oxygen on asexual blood cycle and susceptibility of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay
Malaria Journal volume 6, Article number: 44 (2007)
The main objective of this study was to assess the influence of gas mixtures on in vitro Plasmodium falciparum growth and 50% inhibitory concentration (IC50) for chloroquine.
The study was performed between February 2004 and December 2005. 136 Plasmodium falciparum isolates were used to evaluate gas mixtures effect on IC50 for chloroquine by isotopic microtest. The oxygen effect on asexual blood cycle of 3D7 and W2 clones was determined by thin blood smears examination and tritiated hypoxanthine uptake.
From 5% O2 to 21% O2 conditions, no parasiticide effect of O2 concentration was observed in vitro on the clones 3D7 and W2. A parasitostatic effect was observed during the exposure of mature trophozoïtes and schizonts at 21% O2 with an increase in the length of schizogony. The chloroquine IC50 at 10% O2 were significantly higher than those at 21% O2, means of 173.5 nM and 121.5 nM respectively (p < 0.0001). In particular of interest, among the 63 isolates that were in vitro resistant to chloroquine (IC50 > 100 nM) at 10% O2, 17 were sensitive to chloroquine (IC50 < 100 nM) at 21% O2.
Based on these results, laboratories should use the same gas mixture to realize isotopic microtest. Further studies on comparison of isotopic and non-isotopic assays are needed to establish a standardized in vitro assay protocol to survey malaria drug resistance.
Drug resistance of Plasmodium falciparum, the most deadly human malaria parasite with nearly 500 millions of new clinical cases each year , makes malaria control more difficult [2, 3]. There are basically three approaches to the assessment of the antimalarial drug susceptibility of P. falciparum: in vivo assays as defined by the World Health Organization , in vitro assays and molecular markers of resistance .
In a number of laboratories surveying malaria drug resistance, in vitro tests are performed using the uptake of a radiolabelled nucleic acid precursor [3H]-hypoxanthine  as a marker of parasite growth. Others methods can be used: the WHO schizont maturation tests by optical microscopy (Mark III) with pre-dosed plates , which was based on the method of Rieckmann et al  and of Wernsdorfer , a flow cytometric analysis of propidium iodide incorporation into parasite, which permits a stage-specific evaluation of antimalarial compounds , and colorimetric assays with the measurement of Histidine Rich Protein II (HRP2) by an enzyme-linked immunosorbent assay (ELISA) [11, 12] and the DELI-microtest (Double-site Enzyme-linked Lactate dehydrogenase Immunosorbent assay) [13, 14].
Many factors can influence the results of the chemosusceptibility tests : the initial parasitaemia, the haematocrit, the time of incubation, the time point when [3H]-hypoxanthine is added, the use of serum substitutes and the gas mixture. Laboratories using isotopic microtest to monitor drug resistance work at different oxygen tensions: 3% O2 , 5% O2 [11, 12], 10% O2 , in candle jars [13, 14] (which corresponds to approximately 15% O2 ) and 21% O2  (in CO2 incubators). WHO recommends the use of a candle jar in their in vitro microtests (Mark III). But all have adopted the same threshold for the resistance to antimalarial compounds under different oxygen tensions. The aim of this study was to evaluate the influence of oxygen on the asexual blood cycle and the in vitro chemosusceptibility of P. falciparum to chloroquine in order to contribute to the establishment of a standardized in vitro assay protocol.
Isolates of P. falciparum
Between February 2004 and December 2005, 136 P. falciparum isolates were obtained from patients attending the North Hospital in Marseille  (France). Venous blood was collected into Vacutainer ACD tubes (Becton Dickinson, Rutherford, NJ) before treatment and transported at 4°C to the laboratory in Marseilles, that is associated to the French National Malaria Reference Center. Thin blood smears were stained using a RAL kit (Réactifs RAL, Paris, France) and examined to determine parasite density. Samples with parasitaemia ranging from 0.01% to 6.2% were used to test drug sensitivity. Parasitized erythrocytes were washed three times in RPMI 1640 medium (Invitrogen, Paisley, United Kingdom). If parasitaemia exceeded 0.8%, infected erythrocytes were diluted to 0.5–0.8% with uninfected erythrocytes and resuspended in culture medium to a haematocrit of 1.5%. Susceptibility to chloroquine was determined after suspension in RPMI 1640 medium. The suspensions were supplemented with 10% human serum (AbCys, Paris, France) and buffered with 25 mM HEPES (Sigma, St. Louis, MO) and 25 mM NaHCO3 (Sigma). Isolates were used for 60-hr experiments at two different gas mixtures under 10% O2, 5% CO2, 85% N2 in a CO2 water jacketed incubator series II (Model 3141, Forma Scientific, Inc.) or 21% O2, 5% CO2, 74% N2 in a CO2 incubator (Model MCO-17 AIC, Sanyo).
Chloroquine sensitive 3D7 clone and chloroquine resistant W2 clone (MR4 Resource Center) were used in this study. They were maintained in continuous culture as previously described  at 6% haematocrit using type O+ (3D7) or type A+ (W2) human erythrocytes in the same conditions as described above at 37°C under a 5% CO2, 5% O2, 90% N2 gas mixture and a humidity of 95%. Culture medium was changed every day, viability and parasitaemia of cultured parasites were calculated by light microscopy analysis of blood smear stained with RAL® 555 (Réactifs RAL, France), (5,000 erythrocytes counted per blood smear). Blood smear pictures were performed using a digital camera (Digital Camera DXM 1200, Nikon), and analyzed with the software Lucia 4.8 (Nikon). Parasite synchronization was performed by sorbitol treatment (D-Sorbitol, ICN Biomedicals) as previously described . To obtain tightly synchronized cultures, two sorbitol treatments were carried out 12 h apart. Approximately 48 h after the initial synchronization, the cultures were synchronized again to eliminate any residual schizonts. Clonality was verified every month using PCR genotyping of polymorphic genetic markers (msp1, msp2 and microsatellite loci [21, 22]).
Chloroquine diphosphate was obtained from Sigma Chemical Co. (St. Louis, Mo, U.S.A.). Two-fold serial dilutions of chloroquine were prepared in sterile, distilled water. Final concentrations ranging from 5 nM to 3200 nM were distributed in triplicate into Falcon 96-well flat-bottom plates (Becton Dickinson, Franklin Lakes, N.J.), which were dried.
Oxygen effects on asexual blood cycle of P. falciparum
Synchronous cultures of 3D7 or W2 were divided in three subcultures at 2% initial parasitaemia for 3D7 and 0.5% for W2 and 3% haematocrit under three different oxygen tensions 5% O2, 10% O2 and 21% O2 in three different experiments with duplicates. Culture mediums were not replaced during the experiments. Blood smears were carried out at different times to evaluate parasitaemia and percentages of different stages of parasite (5,000 erythrocytes were counted per blood smear in blind by two different examiners). The same experiments (three different experiments with duplicates) were undertaken with 3D7 parasites with only ten hours exposures of rings stages, trophozoïtes stages or schizonts stages under 21% O2, 5% CO2, 74% N2 gas mixture and under 5% O2, 5% CO2, 90% N2 gas mixture in a CO2 water jacketed incubator series II (Model 3131, Forma Scientific, Inc.) during the rest of the cycle to assess a stage susceptibility of oxygen effect.
Tritiated hypoxanthine uptake
200 μl of the suspension of no parasitized and parasitized erythrocytes (1% parasitaemia, 2% haematocrit) was distributed in 96-well plates (three different experiments with six measurements). Parasite growth was assessed by adding 1 μCi of [3H]-hypoxanthine with a specific activity of 14.1 Ci/mmol (Perkin Elmer, Meriden, NJ) to each well. Plates were incubated for different periods and at different parasites stages at 37°C under 21% O2, 5% CO2, 74% N2 or 10% O2, 5% CO2, 85% N2 gas mixture and a humidity of 95%. Duplicate wells were used to make thin blood smears to evaluate parasitaemia and parasite stages. Immediately after incubation the plates were frozen and then thawed to lyse erythrocytes. The content of each well was collected on standard filter microplates (Unifilter™ GF/B, Perkin Elmer) and washed using a cell harvester (Filtermate™ Cell Harvester, Packard, Meriden, NJ). Filter microplates were dried and 25 μl of scintillation cocktail (Microscint™ O, Perkin Elmer) was placed in each well. Radioactivity incorporated (in counts per minute, cpm) by the parasites was measured using a scintillation counter (Top Count™, Perkin Elmer).
Drug susceptibility assays
The isotopic micro drug susceptibility test used in this study was performed as described previously . The 50% inhibitory concentration (IC50), i.e. the drug concentration corresponding to 50% of the uptake of [3H]-hypoxanthine by the parasites in drug-free control wells, was determined by nonlinear regression analysis of log dose-response curves. Data were analyzed after logarithmic transformation and expressed as the geometric mean IC50 with 95% confidence intervals. The cut-off value for in vitro resistance to chloroquine is 100 nM .
The different results were analyzed with the software STATA 9.0 using a Chi-square test for related samples, a Student's T test or a Wilcoxon signed-rank test (as needed) for related samples. Differences were considered statistically significant when p < 0.05.
In order to determine the effect of oxygen on asexual blood stages of P. falciparum, synchronous cultures of 3D7 were exposed to 5, 10 and 21% O2 during two cycles of parasites. As shown in Figure 1A, there were no significant difference between parasitaemia or parasite stage distribution under 5 and 10% O2 during all the experiment. On the contrary, from 35 h to the rest of experimental points, a significant difference between parasite stages was observed (Figure 2), for example at 40 h, there were 42% of rings and 44.9% of schizonts under 5% O2 and 21.7% of rings and 67.6% of schizonts under 21% O2 (p < 0.001, Chi-square test). After the complete reinvasion around 60 h, parasitaemia were the same in the three experimental conditions and no morphologic alteration were observed by light microscopy (Figures 3A and 3B). These results have shown that parasite exposure under 21% O2 had no lethal effect on parasites, but increased the length of schizogony. Moreover, only mature trophozoïtes and schizonts were susceptible to an effect of exposure to 21% O2 (Figure 4).
The delay was also observed with W2 clone (Figure 1B), with a briefer schizogony (8 hours for W2 and 11 hours 3D7) and a higher multiplication index for W2 (% of infected red blood cells by rings after reinvasion/% of infected red blood cells by rings at the beginning of the previous cycle), (8 for W2 and 3 for 3D7).
No significant difference were observed in tritiated hypoxanthine uptake between 10 and 21% O2 with the two clones 3D7 and W2 (Figures 5A and 5B), (p = 0.087 and p = 0.76 respectively). The maximum of incorporation (around 2,500 cpm with 3D7 and 4,500 cpm with W2) was achieved at 50 hours with a steady-state until 60 hours for 3D7 and W2 in the two experimental conditions. 3D7 and W2 chloroquine IC50 were evaluated under 5, 10 and 21% O2 (three experiments). No significant difference were observed with 3D7, the IC50 were 15.8 nM [10.8–20.7], 14.1 nM [12.4–16.9], 17.6 nM [14.1–21.1] under 5% O2, 10% O2 and 21% O2 respectively. On the contrary, with W2 clone, IC50 under 21% O2 was significantly lower than IC50 under 5% O2 and 10% O2, 83.3 nM [15–168], 299 [228–369] and 277 [192–322] respectively (p < 0.05, Student's T test).
One hundred and thirty six Plasmodium falciparum isolates were used to evaluate chloroquine susceptibility at 10% O2 and 21% O2. Three tests at 10% O2 and 13 tests at 21% O2 were not interpretable, because of lack of significant difference in cpm between control-wells and higher chloroquine concentration wells. Chloroquine susceptibility of 120 isolates was finally tested at 10 and 21% O2 (Figure 6A). The differences between the chloroquine IC50 of the 120 isolates at 10% O2 and at 21% O2 were statistically significant (p < 0.0001, Wilcoxon signed-rank test), means of 173.5 nM with a standard deviation of 168.4 and 121.5 nM with a standard deviation of 106.7 respectively. The median and interquartile (Q25% & Q75%) values of the chloroquine IC50 at 10% O2 and IC50 at 21% O2 of the 120 isolates were respectively 127 nM, 30 nM, 258 nM at 10% O2 and 85.9 nM, 36 nM, 168 nM at 21% O2. In particular of interest, 52.5% of isolates had chloroquine IC50 > 100 nM at 10% O2 although 42.5% of the same isolates had chloroquine IC50 > 100 nM at 21% O2. Moreover, among the 63 isolates which had chloroquine IC50 > 100 nM at 10% O2, 17 had chloroquine IC50 < 100 nM at 21% O2 (Figure 6B) (i.e. 1/3) although five isolates only had chloroquine IC50 > 100 nM at 21% O2 among the 57 isolates which had chloroquine IC50 < 100 nM at 10% O2 (Table 1), (Chi-square test for paired samples, p < 0.025).
There were no significant difference between the observed control cpm at 10 (mean 12,607, standard deviation 13,425) and 21% O2 (mean 13,302, standard deviation 14,662).
The first works about oxygen effects on P. falciparum asynchronous cultures  had shown that microaerophilic environment allowed an optimal development of parasites. Their growth was impossible in strict anaerobic conditions. P. falciparum possesses a functional mitochondrial respiratory chain with oxygen consumption . It has been shown that there is some protector effect of CO2 at high oxygen concentration  through the medium pH which stability (between 7.2 et 7.45) is required for parasite growth . The analysis of the different parasites stages distribution according to the time and the oxygen concentration has allowed us to reveal a possible slow down of cellular cycle without morphologic alteration of parasites under 21% O2.
In the present study, the exposure to 21% O2 did not change parasitaemia growth rate after complete reinvasion. Previous studies  had shown the same absence of oxygen effect on synchronous cultures parasitaemia during four days. Here, it has been shown that the exposure of 3D7 and W2 P. falciparum clones to 21% O2 had parasitostatic effect by lengthening the schizogony. Mature stages had a particular susceptibility to high oxygen concentration. Moreover, these results justified to test drug susceptibility after a 60 hours period of incubation with [3H]-hypoxanthine. At the end of trophozoïtes stage, DNA replication begins and is followed by a succession of S phases during the schizogony . Under 21% O2, the nucleic acids synthesis decreased from 30 hours for the two P. falciparum clones comparing to 5% O2 exposure. Under 5% O2, a low [3H]-hypoxanthine incorporation took place for the first twenty hours, probably corresponding to RNA synthesis in rings, followed by an increase between 20 and 30 hours in possible relation with the beginning of DNA replication at late trophozoïtes stage . Between 30 and 40 hours, during schizogony, DNA synthesis increased and the peak was achieved at 50 hours .
In the present study, the chloroquine IC50 at 10% O2 were significantly higher than those at 21% O2. A previous study did not show oxygen dependent effects of chloroquine on P. falciparum in culture , but in that experiment only four strains were tested. In the present work, among the 63 isolates which had chloroquine IC50 > 100 nM at 10% O2, 17 had chloroquine IC50 < 100 nM at 21% O2. The effect of gas mixture on the results of chloroquine chemosusceptibility should led different laboratories involved in malaria resistance survey to adapt a resistance threshold for each gas mixture or to use the same conditions to perform isotopic microtests.
Several factors influencing the results of the chemosusceptibility tests (the initial parasitaemia, the haematocrit, the time of incubation, the time point when [3H]-hypoxanthine is added, the use of serum substitutes) have already been investigated by Basco [15, 32]. The present data suggest the importance of the gas mixture on isotopic microtest results for chloroquine. Further studies are needed to evaluate gas mixture impact on isolates susceptibility to other antimalarial compounds and their correlation with molecular markers of resistance and in vivo evaluation of drug efficacy. Other investigations about the preparation of drug solutions, the storage of pre-dosed culture plates are required before in vitro drug sensitivity assay can become a standardized tool for laboratories to validate the threshold for resistance in respect to the clinical responses and molecular markers.
Conflict of interest
The author(s) declare that they have no competing interests.
The views and opinions are those of the authors and do not purport to represent those of the French Ministry of Defense.
Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI: The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 2005, 434 (7030): 214-217. 10.1038/nature03342.
Wernsdorfer WH: The development and spread of drug-resistant malaria. Parasitol Today. 1991, 7 (11): 297-303. 10.1016/0169-4758(91)90262-M.
Trape JF, Pison G, Spiegel A, Enel C, Rogier C: Combating malaria in Africa. Trends Parasitol. 2002, 18 (5): 224-230. 10.1016/S1471-4922(02)02249-3.
WHO: Susceptibility of Plasmodium falciparum to antimalarial drugs. Reports on global monitoring 1996-2004. in WHO/HTM/MAL/2005.1103 Geneva: WHO 2005:
Le Bras J, Musset L, Clain J: Antimalarial drug resistance. Med Mal Infect. 2006, 36 (8): 401-405.
Desjardins RE, Canfield CJ, Haynes JD, Chulay JD: Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979, 16 (6): 710-718.
WHO: In vitro micro-test (Mark III) for the assessment of the response of Plasmodium falciparum to chloroquine, mefloquine, quinine, amodiaquine, sulfadoxine/pyrimethamine and artemisinin. In WHO/CTD/MAL/97.20 Rev 2 2001. Geneva: WHO; 2001.:
Rieckmann KH, Campbell GH, Sax LJ, Mrema JE: Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique. Lancet. 1978, 1 (8054): 22-23. 10.1016/S0140-6736(78)90365-3.
Wernsdorfer WH: Field evaluation of drug resistance in malaria. In vitro micro-test. Acta Trop. 1980, 37 (3): 222-227.
Contreras CE, Rivas MA, Dominguez J, Charris J, Palacios M, Bianco NE, Blanca I: Stage-specific activity of potential antimalarial compounds measured in vitro by flow cytometry in comparison to optical microscopy and hypoxanthine uptake. Mem Inst Oswaldo Cruz. 2004, 99 (2): 179-184. 10.1590/S0074-02762004000200011.
Noedl H, Wernsdorfer WH, Miller RS, Wongsrichanalai C: Histidine-rich protein II: a novel approach to malaria drug sensitivity testing. Antimicrob Agents Chemother. 2002, 46 (6): 1658-1664. 10.1128/AAC.46.6.1658-1664.2002.
Noedl H, Bronnert J, Yingyuen K, Attlmayr B, Kollaritsch H, Fukuda M: Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing. Antimicrob Agents Chemother. 2005, 49 (8): 3575-3577. 10.1128/AAC.49.8.3575-3577.2005.
Druilhe P, Moreno A, Blanc C, Brasseur PH, Jacquier P: A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay. Am J Trop Med Hyg. 2001, 64 (5-6): 233-241.
Dieng T, Bah IB, Ndiaye PM, Diallo I, Diop BM, Brasseur P, Mboup S, Wirth D, Ndir O: In vitro evaluation of the sensitivity of Plasmodium falciparum to chloroquine using the deli-microtest in region of Dakar, Senegal. Med Trop (Mars). 2005, 65 (6): 580-583.
Basco LK: Molecular epidemiology of malaria in cameroon. XX. Experimental studies on various factors of in vitro drug sensitivity assays using fresh isolates of Plasmodium falciparum. Am J Trop Med Hyg. 2004, 70 (5): 474-480.
Pradines B, Spiegel A, Rogier C, Tall A, Mosnier J, Fusai T, Trape JF, Parzy D: Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates. Am J Trop Med Hyg. 2000, 62 (1): 82-85.
Scheibel LW, Ashton SH, Trager W: Plasmodium falciparum: microaerophilic requirements in human red blood cells. Exp Parasitol. 1979, 47 (3): 410-418. 10.1016/0014-4894(79)90094-8.
Parola P, Soula G, Gazin P, Foucault C, Delmont J, Brouqui P: Fever in travelers returning from tropical areas: prospective observational study of 613 cases hospitalised in Marseilles, France, 1999-2003. Travel Med Infect Dis. 2006, 4 (2): 61-70. 10.1016/j.tmaid.2005.01.002.
Trager W, Jensen JB: Human malaria parasites in continuous culture. Science. 1976, 193 (4254): 673-675. 10.1126/science.781840.
Lambros C, Vanderberg JP: Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979, 65 (3): 418-420. 10.2307/3280287.
Bogreau H, Renaud F, Bouchiba H, Durand P, Assi SB, Henry MC, Garnotel E, Pradines B, Fusai T, Wade B, Adehossi E, Parola P, Kamil MA, Puijalon O, Rogier C: Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas. Am J Trop Med Hyg. 2006, 74 (6): 953-959.
Henry M, Diallo I, Bordes J, Ka S, Pradines B, Diatta B, M'Baye PS, Sane M, Thiam M, Gueye PM, Wade B, Touze JE, Debonne JM, Rogier C, Fusai T: Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates. Am J Trop Med Hyg. 2006, 75 (1): 146-151.
Pradines B, Hovette P, Fusai T, Atanda HL, Baret E, Cheval P, Mosnier J, Callec A, Cren J, Amalvict R, Gardair JP, Rogier C: Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo. J Clin Microbiol. 2006, 44 (7): 2404-2408. 10.1128/JCM.00623-06.
Le Bras J, Ringwald P: Plasmodium falciparum chemoresistance. The situation in Africa in 1989. Med Trop (Mars). 1990, 50 (1): 11-16.
Krungkrai J, Burat D, Kudan S, Krungkrai S, Prapunwattana P: Mitochondrial oxygen consumption in asexual and sexual blood stages of the human malarial parasite, Plasmodium falciparum. Southeast Asian J Trop Med Public Health. 1999, 30 (4): 636-642.
Jensen MD, Conley M, Helstowski LD: Culture of Plasmodium falciparum: the role of pH, glucose, and lactate. J Parasitol. 1983, 69 (6): 1060-1067. 10.2307/3280864.
Miyagami T, Waki S: In vitro cultivation of Plasmodium falciparum under aerobic atmosphere in a CO2 incubator. J Parasitol. 1985, 71 (2): 262-263. 10.2307/3281915.
Doerig C CD: The cell cycle in protozoan parasites. Progress in Cell Cycle Research. Edited by: Edited by Meijer L JADB. 2000, New York , Kluwer Academic and Plenum, Volume 4: 163-183.
Gritzmacher CA, Reese RT: Protein and nucleic acid synthesis during synchronized growth of Plasmodium falciparum. J Bacteriol. 1984, 160 (3): 1165-1167.
Inselburg J, Banyal HS: Synthesis of DNA during the asexual cycle of Plasmodium falciparum in culture. Mol Biochem Parasitol. 1984, 10 (1): 79-87. 10.1016/0166-6851(84)90020-3.
Divo AA, Geary TG, Jensen JB: Oxygen- and time-dependent effects of antibiotics and selected mitochondrial inhibitors on Plasmodium falciparum in culture. Antimicrob Agents Chemother. 1985, 27 (1): 21-27.
Basco LK: Molecular epidemiology of malaria in Cameroon. XXIII. Experimental studies on serum substitutes and alternative culture media for in vitro drug sensitivity assays using clinical isolates of Plasmodium falciparum. Am J Trop Med Hyg. 2006, 75: 777-782.
We thank the Parasitology staff of the Institut de Médecine Tropicale du Service de Santé des Armées for technical assistance. This work was supported by the French Ministry of Defense.
SB contributed to the design and execution of the study, data analysis and prepared the first draft of the manuscript. PP contributed to the data collect and drafting of the manuscript. TF contributed to the design of the study and drafting of the manuscript. MMF contributed to the execution of the study and writing of the manuscript. EB contributed to the execution of the study. JM contributed to the execution of the study. JPD contributed to the data collect and the intellectual content of the manuscript. DP contributed to the study design. PM contributed to the data collect and the intellectual content of the manuscript. CR contributed to the study design as well as data analysis and writing of the manuscript. BP contributed to the study design, data analysis and writing of the manuscript.
Authors’ original submitted files for images
About this article
Cite this article
Briolant, S., Parola, P., Fusaï, T. et al. Influence of oxygen on asexual blood cycle and susceptibility of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay. Malar J 6, 44 (2007). https://doi.org/10.1186/1475-2875-6-44
- Drug Susceptibility
- Thin Blood Smear
- Oxygen Effect